Alex Kelly Email and Phone Number
Alex Kelly work email
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
Alex Kelly personal email
- Valid
Alex Kelly phone numbers
With a combined background in corporate affairs, communications, IR, integrations, M&A, and sales, I know how to lead teams, work fast, deliver value from deals, and create excitement for change! I have used compelling storytelling to influence key internal and external stakeholders, including investors, sell-side analysts, and credit rating agencies, in addition to leading award-winning investor relations teams and managing $100B in back-to-back and overlapping integrations for fast-moving, highly transactive global companies. With a trailblazer mentality, I thrive in white space opportunities where I can help companies be the first to break new ground. Crafting the Allergan Social Contract was very meaningful to me, to our employees, to our board of directors and to our stakeholders. It was the first articulation by a large biopharma company of our commitment to provide accessible and affordable medicines to patients. I’m all for authentic culture rather than building bureaucracy and silos, and the most rewarding experiences have involved working with teams to achieve unexpected success.Across the industry, I have broad advocacy experience with extensive participation on industry and nonprofit boards. Currently, I am a member and Vice Chair of the California Life Sciences Association, and past Treasurer. I have also served as Chair and Treasurer of the HealthCare Institute of NJ and as President of The Allergan Foundation. Specialties: Acquisition Integration, Investor Relations, Communications, Debt & Equity Offerings, Mergers & Acquisitions, IPO, Turnarounds, Crisis & Change Management, Deal & Non-Deal Roadshows, International Investing, Disease States & Therapies, Corporate Social Responsibility, Turnarounds
Precision Biosciences, Inc.
View-
Chief Financial OfficerPrecision Biosciences, Inc. Jan 2021 - PresentDurham, North Carolina, Us -
Chief Corporate Affairs OfficerPrecision Biosciences, Inc. Oct 2020 - May 2021Durham, North Carolina, Us -
Executive Vp, Corporate Affairs & Chief Communications OfficerAllergan 2015 - May 2020Dublin, Coolock, IeMember of the executive leadership team that reshaped Allergan after a series of rapid and transformational transactions, including the acquisition by Actavis (while keeping the Allergan name). Established internal and external messaging to support transformations, including the sale of the generic business in 2015, a proposed (and withdrawn) merger with Pfizer in 2016, a restructuring in 2017, and the run up to the merger with AbbVie in 2019 and 2020. Partnered with the CEO to create Allergan’s Social Contract with Patients, the first commitment by a large biopharma company to provide accessible and affordable medicines. Orchestrated development of Allergan’s “Bold for Life” culture. Recruited, hired, and developed a new corporate affairs leadership team covering all communications, government affairs, and patient advocacy functions. -
President, The Allergan FoundationAllergan 2015 - 2020Dublin, Coolock, IeMade a lasting impact in the communities where Allergan colleagues live and work. Over its 21 year history, the Allergan Foundation awarded more than $115 million in charitable grants as of May 2020, including $50 million in donations over five years. -
Senior Vice President, Chief Integration OfficerActavis Plc (Now Allergan) 2014 - 2015Dublin, IeReported to Chief Operating Officer. Promoted as Actavis acquired Forest Laboratories to lead integration efforts and pivoted quickly to planning the integration of Allergan. Managed the complexity of multiple integrations while delivering more than $2.8B in synergies. Managed integration for the $28B acquisition of Forest Labs (announced in February 2014 and closed in July 2014), as well as the $70B Allergan acquisition (announced in November 2014 and closed in March 2015). Beat the three-year Forest synergy target of $1B within nine months. Exceeded Allergan synergy target of $1.8B in 12 months. -
Sr. Vice President, Chief Communications Officer, Public Affairs And Investor RelationsForest Labs 2013 - 2014Recruited by and reported to CEO to build a respected, consolidated corporate communications and investor relations team within an organization that had traditionally downplayed external communications. Recruited a six-person team from within the company to align resources to support public relations, corporate communications, internal communications, and investor relations initiatives. Led integration of Forest’s $2.9B acquisition of Aptalis Pharma, a privately-held (TPG) maker of gastrointestinal and cystic fibrosis drugs (in February 2014) to significantly expanded Forest’s GI portfolio and increase its international footprint. -
Vice President, Investor RelationsBausch + Lomb May 2013 - Aug 2013Bridgewater, Nj, UsRecruited to lead investor relations leading into B+L’s IPO (canceled within weeks when the Valeant deal was announced). -
Senior Vice President, Investor RelationsMerck 2009 - 2013Rahway, New Jersey, UsAssumed leadership of an investor relations team that had struggled to gain credibility with investors and analysts in the years after the company recalled Vioxx (leading to lawsuits, lost revenue, and major restructurings). Team received recognition by Institutional Investor for having the Best IR Program in Pharma in 2011 as a result of counseling management to execute shareholder friendly actions, including the first dividend increase in seven years and a $15B share buy-back, and focusing investors on the value of the research pipeline. -
Group Vp, Global Communications And Investor RelationsSchering-Plough 2007 - 2009Recruited by CEO (former CEO at Pharmacia) to lead global IR team support the turnaround of a business that had recently suffered from declining sales, manufacturing consent decree, legal challenges, and significant fines related to a Reg FD settlement in 2003. Member of the operations leadership team. Assumed leadership of the global IR team, adding Global Communications functions after the acquisition of Organon BioSciences (OBS) in 2007. Reported to CFO and to General Counsel.
-
Vp, Investor RelationsSchering-Plough 2004 - 2007
-
Executive Director, Investor RelationsNovartis 2003 - 2004Basel, Baselstadt, ChRecruited to lead US IR team. Served a six-month rotation at the company headquarters in Switzerland to gain familiarity with company leadership and more intimate knowledge of international investors. Worked on team to showcase the newly created $10B Sandoz generics business. Developed materials for analyst meeting to put a spotlight on the branded R&D pipeline. -
Sr. Director, Investor RelationsPharmacia 2002 - 2003Recruited from field sales force due to exceptional drug and disease state knowledge needed to highlight competitive position and respond to investor/analyst questions. Developed deeper expertise from key internal relationships with R&D and commercial teams. Promoted twice in three years. Led day-to-day communications with investors and analysts.
-
Director, Investor RelationsPharmacia & Upjohn 1999 - 2002 -
District Sales ManagerPharmacia & Upjohn 1996 - 1999Promoted from Critical Care sales to District Sales Manager. Led 12 representatives selling CNS, diabetes, women's health, oncology, urology, and eye care products. -
Pharmaceutical Sales RepresentativeThe Upjohn Company 1989 - 1996Primary Care Sales RepresentativeHospital Sales RepresentativeCritical Care Sales Specialist
Alex Kelly Skills
Alex Kelly Education Details
-
Purdue UniversityPharmacy
Frequently Asked Questions about Alex Kelly
What company does Alex Kelly work for?
Alex Kelly works for Precision Biosciences, Inc.
What is Alex Kelly's role at the current company?
Alex Kelly's current role is C-Suite Biopharmaceutical Executive | Finance | Corporate Affairs | Investor Relations | Communications Operations | M&A.
What is Alex Kelly's email address?
Alex Kelly's email address is ke****@****gan.com
What is Alex Kelly's direct phone number?
Alex Kelly's direct phone number is (908)-298*****
What schools did Alex Kelly attend?
Alex Kelly attended Purdue University.
What skills is Alex Kelly known for?
Alex Kelly has skills like Investor Relations, Pharmaceutical Industry, Leadership, Mergers And Acquisitions, Cross Functional Team Leadership, Strategy, Executive Management, Biotechnology, Corporate Communications, Communication Training, Crisis Management, Strategic Communications.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial